Last update 14 Dec 2024

Bindarit

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bindarit (USAN/INN), AF-2838
Target
Mechanism
CCL2 inhibitors(C-C motif chemokine 2 inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC19H20N2O3
InChIKeyMTHORRSSURHQPZ-UHFFFAOYSA-N
CAS Registry130641-38-2

External Link

KEGGWikiATCDrug Bank
D03116--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Coronary RestenosisPhase 2
IT
01 Jan 2009
AlbuminuriaPhase 2
IT
01 Mar 2007
AlbuminuriaPhase 2
SI
01 Mar 2007
Diabetic NephropathiesPhase 2
IT
01 Mar 2007
Diabetic NephropathiesPhase 2
SI
01 Mar 2007
Lupus NephritisPhase 2
IT
-
Rheumatoid ArthritisPhase 2
US
-
Rheumatoid ArthritisPhase 2
IT
-
Rheumatoid ArthritisPhase 2
GB
-
PancreatitisPreclinical
IT
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
Bindarit 600 mg twice daily
iivapwwaiy(rqezxsmkki) = yybhuqwmqi esnhmdqpqi (qnowayisfo )
Positive
16 Nov 2010
Placebo
iivapwwaiy(rqezxsmkki) = zoepxmrune esnhmdqpqi (qnowayisfo )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free